- Health Conditions
- Events
- MedWire
- Visit A Doctor
- Medimorphosis
- HCP Portal
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Medication & Drugs
A new cholesterol pill has joined a class once available only as injections. Here is how enlicitide works, what trials found and why it may sit alongside your statin.
Smaller meals, protein shakes, fibre gummies and another vitamin bottle. GLP-1 users are building supplement routines around their medication…but which products address a real need, and when should you seek advice?
A promising weight-loss medication helped trial participants lose an average of 25% of their weight at the highest dose. But some needed doses reduced, raising a question: when should further weight loss stop being the goal?
There is no excerpt because this is a protected post.
Weight-loss drugs are facing a bowel cancer question, but the findings are far from settled. We unpack the GLP-1 research, the distinction between polyps and cancer, and what patients should discuss with their doctor.
GLP-1 drugs may do more than suppress appetite. Early trials suggest semaglutide can reduce alcohol cravings and heavy drinking, although it remains an unproven addiction treatment.
Clomiphene has long been used in fertility care across Asia. New research suggests higher cumulative exposure may increase miscarriage and multiple birth risks without improving the chance of a live birth.
Why does psoriasis keep returning? Dermatologist Dr Joseph Toh explains its immune-related causes and when biologic therapy may help improve long-term control.
Scientists have reversed newly diagnosed Type 1 diabetes in mice using engineered stem cells that reprogramme the immune system instead of replacing insulin.
Subscribe to Updates
Subscribe to receive latest health related news from us
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.